Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | Carbon tetrabromide | HCID 11205 | — |
| Reactant | Triphenylphosphine | HCID 11776 | — |
| Reactant | HCID 66811536 | HCID 66811536 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 66811607 | HCID 66811607 | 96% |
Reaction Steps
To a solution of tert-butyl 2-{[2-({1-[(benzyloxy)carbonyl]azetidin-3-yl}carbonyl)hydrazino]carbonyl}-3-phenylpiperidine-1-carboxylate (235 mg, 0.44 mmol) in dichloromethane (4 ml) at 0° C. were added imidazole (71.6 mg, 1.05 mmol), polystyrene bound triphenyl phosphine (471 mg, 0.96 mmol, 2.04 g/mmol), and carbon tetrabromide (320 mg, 0.96 mmol). The reaction was warmed to rt and allowed to stir for 18 h. The reaction mixture was filtered and rinsed with dichloromethane. The filtrate was concentrated to give an oil. The crude material was purified via flash chromatography (silica, 0-35% EtOAc/hexanes) to yield tert-butyl 2-(5-{1-[(benzyloxy)carbonyl]azetidin-3-yl}-1,3,4-oxadiazol-2-yl)-3-phenylpiperidine-1-carboxylate (96%) as a colorless oil.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08143405B2 |
|---|
| Source dataset | uspto-grants-2012_03 |
|---|
| ORD ID | ord-6d15d1416b67463985bfbd691c25386f |
|---|
| Source note | uspto-grants-2012_03 |
|---|